Avonex Pen is used to inject Avonex. The active ingredient in Avonex is a protein called interferon beta-1a. Interferons are natural substances made in the body to help protect from infections and diseases. The protein in Avonex is made up of exactly the same ingredients as interferon beta that is found in the human body.
Excipients/Inactive Ingredients: Sodium acetate, trihydrate; acetic acid glacial, arginine hydrochloride, polysorbate 20 and water for injections.
Multiple sclerosis is linked to nerve (brain or spinal cord) damage. In MS, the body's defence system reacts against its own myelin - the 'insulation' that surrounds nerve fibres. When myelin is damaged, the messages between the brain and other parts of the body are disrupted. This is what causes the symptoms of MS. Avonex seems to work by stopping the body's defence system from attacking the myelin.
Avonex is used to treat Multiple Sclerosis (MS). Treatment with Avonex can help to prevent patient from getting worse, although it will not cure MS.
Everyone has their own set of MS symptoms. These can include: Feeling off-balance or light-headed, walking problems, stiffness and muscle spasms, tiredness, numbness in the face, arms or legs; Acute or chronic pain, bladder and bowel problems, sexual problems and problems seeing things; Difficulty in thinking and concentrating, depression.
MS also tends to flare up from time to time: this is called a relapse.
Avonex can help to reduce the number of relapses and slow down the disabling effects of MS. The doctor will advise for how long Avonex can be used or when to stop.
The recommended weekly dose: One injection using Avonex Pen, once a week.
Try to use Avonex at the same time on the same day each week.
Not for children: Avonex is not to be used in children below the age of 12 years.
Injecting: The patient can self-inject Avonex using the Avonex Pen without the help of the doctor, if he/she has trained to do this. The instructions on how to inject are at the Patient Counselling Informaton Section (see How to inject AVONEX PEN under Patient Counselling Information).
In case of trouble in handling the Avonex Pen, ask the doctor who may be able to help.
How long to use AVONEX: The doctor will advise how long the patient will need to keep using Avonex. It is important to continue using Avonex regularly. Do not make changes unless advised by the doctor.
If the patient misses an injection: If the patient misses the usual weekly dose, inject a dose as soon as possible. Then leave a week before using Avonex Pen again. Continue injecting on this new day every week. If he/she has a preferred day for using Avonex, talk to the doctor about managing the dose, to get back to the preferred day. Do not use two injections to make up for a missed injection.
If the patient injects more than the prescribed: The patient should inject using only one Avonex Pen, once a week. If the patient used more than one Avonex Pen in a three-day period, contact the doctor or pharmacist straight away for advice.
Do not use AVONEX: If the patient is allergic to interferon beta or any of the other ingredients of this medicine (listed in Description).
If the patient has severe depression or thinks about committing suicide.
Talk to a doctor straight away if any of these apply to the patient.
Avonex and allergic reactions: Because Avonex is based on a protein, there is a small chance of an allergic reaction.
More about depression: If the patient has severe depression or thoughts about suicide, do not use Avonex.
In case of depression, the doctor may still prescribe Avonex, but it's important to let the doctor know if the patient had depression or any similar problems affecting moods.
Talk to the doctor before using Avonex if the patient has or had in the past: Depression or problems affecting the moods.
Thoughts about committing suicide.
Changes to the mood, thoughts about suicide, feeling unusually sad, anxious or worthless, should be reported to the doctor immediately.
Epilepsy or other seizure disorders not controlled by medication.
Serious kidney or liver problems.
A low number of white blood cells or platelets, which can cause an increased risk of infection, bleeding or anaemia.
Heart problems, which can cause symptoms such as chest pain (angina), particularly after any activity; swollen ankles, shortness of breath (congestive heart failure); or an irregular heartbeat (arrhythmias).
Talk to the doctor in the event of any of these conditions, or if they worsen whilst taking Avonex.
Blood clots in the small blood vessels may occur during treatment. These blood clots could affect the kidneys. This might happen several weeks to several years after starting Avonex.
The doctor may want to check the blood pressure, blood (platelet count) and function of the kidneys.
Thrombotic microangiopathy (TMA): Cases of thrombotic microangiopathy, manifested as thrombotic thrombocytopenic purpura (TTP) or haemolytic uraemic syndrome (HUS), including fatal cases, have been reported with interferon beta products. Events were reported at various time points during treatment and may occur several weeks to several years after starting treatment with interferon beta. Early clinical features include thrombocytopenia, new onset hypertension, fever, central nervous system symptoms (e.g. confusion, paresis) and impaired renal function. Laboratory findings suggestive of TMA include decreased platelet counts, increased serum lactate dehydrogenase (LDH) due to haemolysis and schistocytes (erythrocyte fragmentation) on a blood film. Therefore if clinical features of TMA are observed, further testing of blood platelet levels, serum LDH, blood films and renal function is recommended. If TMA is diagnosed, prompt treatment is required (considering plasma exchange) and immediate discontinuation of Avonex is recommended.
Nephrotic Syndrome: Cases of nephrotic syndrome with different underlying nephropathies including collapsing focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranoproliferative glomerulonephritis (MPGN) and membranous glomerulopathy (MGN) have been reported during treatment with interferon-beta products. Events were reported at various time points during treatment and may occur after several years of treatment with interferon-beta. Periodic monitoring of early signs or symptoms, e.g. oedema, proteinuria and impaired renal function is recommended, especially in patients at higher risk of renal disease. Prompt treatment of nephrotic syndrome is required and discontinuation of treatment with Avonex should be considered.
Tell the doctor that the patient is using Avonex: If he/she is having a blood test, Avonex may interfere with the results.
Important information about some of the ingredients of Avonex: This medicine is essentially 'sodium-free'. It contains less than 23 mg (1 mmol) sodium in each weekly dose.
Driving and using machines: If the patient feels dizzy, do not drive. Avonex makes some people feel dizzy. If this happens, or if the patient gets any other side effects that could affect the ability, do not drive or use machines.
If the patient is pregnant, thinks she is pregnant or is planning to have a baby, ask the doctor or pharmacist for advice before taking this medicine.
No harmful effects on the breastfed newborn/infants are anticipated. Avonex can be used during breast-feeding.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects: Get medical help.
Serious allergic reactions: If the patient gets any of these: Swelling of the face, lips or tongue; Difficulty breathing; A rash.
Call a doctor immediately. Do not use any more Avonex until the patient has spoken to a doctor.
Depression: If the patient gets any symptoms of depression: Feeling unusually sad, anxious or worthless.
Call a doctor immediately.
Liver problems: If the patient gets any of these symptoms: Yellowing of the skin or the whites of the eyes (jaundice); Itching all over; Feeling sick, being sick (nausea and vomiting); Easy bruising of the skin.
Call a doctor immediately as they may be signs of a possible liver problem.
Side effects seen in clinical trials: These are the side effects that people reported when Avonex was being tested. The figures are based on how many people said they had them. It gives an idea how likely the patient is to get similar side effects.
Very common side effects (may affect more than 1 in 10 people): Flu-like symptoms - headache, muscle aches, chills or a fever: see Flu-like symptoms as follows; Headache.
Common side effects (may affect up to 1 in 10 people): Loss of appetite; Feeling weak and tired; Difficulty sleeping; Depression; Flushing; Runny nose; Diarrhoea (loose stools); Feeling or being sick (nausea or vomiting); Numbness or tingling of skin; Rash, bruising of the skin; Increased sweating, night sweats; Pain in the muscles, joints, arms, legs or neck; Muscle cramps, stiffness in the joints and muscles; Pain, bruising and redness at the injection site; Changes to blood tests- Symptoms the patient might notice are tiredness, repeated infection, unexplained bruising or bleeding.
Uncommon side effects (may affect up to 1 in 100 people): Hair loss; Changes to the monthly period; Burning feeling at the site of injection.
Rare side effects (may affect up to 1 in 1,000 people): Difficulty breathing; Kidney problems including scarring that may reduce the kidney function.
If the patient gets some or all of these symptoms: Foamy urine; Fatigue; Swelling, particularly in the ankles and eyelids, and weight gain. Tell the doctor as they may be signs of a possible kidney problem.
Blood clots in the small blood vessels that can affect the kidneys (thrombotic thrombocytopenic purpura or haemolytic uremic syndrome). Symptoms may include increased bruising, bleeding, fever, extreme weakness, headache, dizziness or light-headedness. The doctor may find changes in the blood and the function of the kidneys.
If any of the effects trouble the patient, talk to the doctor.
Other side effects: These effects have been seen in people using Avonex, but the likelihood of occurrence is not certain.
An underactive or overactive thyroid.
Nervousness or anxiety, emotional instability, irrational thoughts or hallucinations (seeing or hearing things that are not real), confusion or suicide.
Numbness, dizziness, seizures or fits and migraines.
An awareness of the heartbeat (palpitations), a rapid or irregular heartbeat, or heart problems which would have the following symptoms: a reduced ability to exercise, inability to lie flat in bed, shortness of breath or swollen ankles.
Liver problems as described previously.
Nettle rash or blister-like rash, itching, worsening of psoriasis, if the patient has it.
Swelling or bleeding at the site of injection, or chest pain after an injection.
Gaining or losing weight.
Changes to test results, including changes to liver function tests.
Pulmonary arterial hypertension: A disease of severe narrowing of the blood vessels in the lungs resulting in high blood pressure in the blood vessels that carry blood from the heart to the lungs. Pulmonary arterial hypertension has been seen at various time points during treatment, including several years after starting treatment with interferon beta-products.
If any of the effects trouble the patient, talk to the doctor.
Effects of the injection: Feeling faint: The first injection of Avonex may be given by the doctor. It may make the patient feel faint. He/she may even actually faint. This is unlikely to happen again.
Just after an injection, the muscles may feel tense or very weak - as though having a relapse. This is rare. It only happens when the patient injects and the effects soon pass. They may happen any time after starting on Avonex.
If the patient notices any irritation or skin problems after an injection, talk to the doctor.
Flu-like symptoms: Some people find that after using Avonex Pen, they feel like they have flu. Signs are: Headache, Muscle aches, Chills or a fever.
These symptoms are not really flu. The patient can't pass it on to anyone else. They are more common when he/she first starts using Avonex. As the patient keeps using the injections, the flu-like symptoms gradually decrease.
Three simple ways to help reduce the impact of flu-like symptoms: Use Avonex Pen injection just before bedtime. This may allow the patient to sleep through the effects.
Take paracetamol or ibuprofen half an hour before Avonex Pen injection and continue taking it for up to a day. Speak to the doctor or pharmacist about a suitable dose.
If the patient has a fever, drink plenty of water to keep hydrated.
Reporting of side effects: If the patient gets any side effects, talk to the doctor or pharmacist. This includes any possible side effects not listed. By reporting side effects, it can help provide more information on the safety of this medicine.
Tell the doctor if the patient is using, has recently used or might use any other medicines, especially those used to treat epilepsy or depression. Avonex may affect other medicines or be affected by them. This includes any medicines without a prescription.
Do not use Avonex Pen if: The pen is broken.
The solution is coloured or particles can be seen floating in it.
The tamper evident cap has been broken.
Do not throw away any medicines via wastewater or household waste. Ask the pharmacist how to throw away medicines no longer use. These measures will help to protect the environment.
Store in the original package in order to protect from light.
Store in a refrigerator (between 2°C and 8°C). Do not freeze.
Avonex Pen can be stored at room temperature (between 15°C and 30°C) for up to one week.
Keep this medicine out of the sight and reach of children.
L03AB07 - interferon beta-1a ; Belongs to the class of interferons. Used as immunostimulants.
Avonex pre-filled inj 30 mcg/0.5 mL
4 × 1's